152 related articles for article (PubMed ID: 11336796)
1. Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro.
Bueb JL; Lambert DM; Tschirhart EJ
Biochim Biophys Acta; 2001 Apr; 1538(2-3):252-9. PubMed ID: 11336796
[TBL] [Abstract][Full Text] [Related]
2. Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells.
Lau AH; Chow SS
Eur J Pharmacol; 2003 Mar; 464(2-3):229-35. PubMed ID: 12620517
[TBL] [Abstract][Full Text] [Related]
3. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.
Facci L; Dal Toso R; Romanello S; Buriani A; Skaper SD; Leon A
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3376-80. PubMed ID: 7724569
[TBL] [Abstract][Full Text] [Related]
4. The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1998 Oct; 125(3):533-41. PubMed ID: 9806337
[TBL] [Abstract][Full Text] [Related]
5. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.
Pertwee RG; Stevenson LA; Griffin G
Br J Pharmacol; 1993 Dec; 110(4):1483-90. PubMed ID: 8306090
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Leon A
Glia; 2003 Jan; 41(2):161-8. PubMed ID: 12509806
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.
Wiley JL; Martin BR
Chem Phys Lipids; 2002 Dec; 121(1-2):57-63. PubMed ID: 12505690
[TBL] [Abstract][Full Text] [Related]
8. The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro.
Jonsson KO; Persson E; Fowler CJ
Life Sci; 2006 Jan; 78(6):598-606. PubMed ID: 16111718
[TBL] [Abstract][Full Text] [Related]
9. Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta.
O'Sullivan SE; Kendall DA; Randall MD
Eur J Pharmacol; 2005 Jan; 507(1-3):211-21. PubMed ID: 15659311
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide.
Ross RA; Brockie HC; Pertwee RG
Eur J Pharmacol; 2000 Aug; 401(2):121-30. PubMed ID: 10924916
[TBL] [Abstract][Full Text] [Related]
11. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.
Houser SJ; Eads M; Embrey JP; Welch SP
Brain Res; 2000 Feb; 857(1-2):337-42. PubMed ID: 10700588
[TBL] [Abstract][Full Text] [Related]
12. A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story..
Dalle Carbonare M; Del Giudice E; Stecca A; Colavito D; Fabris M; D'Arrigo A; Bernardini D; Dam M; Leon A
J Neuroendocrinol; 2008 May; 20 Suppl 1():26-34. PubMed ID: 18426496
[TBL] [Abstract][Full Text] [Related]
13. Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes.
Bloom AS; Edgemond WS; Moldvan JC
Neurochem Res; 1997 May; 22(5):563-8. PubMed ID: 9131634
[TBL] [Abstract][Full Text] [Related]
14. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.
Lauckner JE; Hille B; Mackie K
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19144-9. PubMed ID: 16365309
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors.
Farquhar-Smith WP; Jaggar SI; Rice AS
Pain; 2002 May; 97(1-2):11-21. PubMed ID: 12031775
[TBL] [Abstract][Full Text] [Related]
17. Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta.
Van den Bossche I; Vanheel B
Br J Pharmacol; 2000 Sep; 131(1):85-93. PubMed ID: 10960073
[TBL] [Abstract][Full Text] [Related]
18. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed.
Duncan M; Kendall DA; Ralevic V
J Pharmacol Exp Ther; 2004 Oct; 311(1):411-9. PubMed ID: 15205450
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of monoamine oxidase activity by cannabinoids.
Fisar Z
Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):563-72. PubMed ID: 20401651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
